Apnimed Raises $62.5M to Advance Lead Sleep Apnea Pill Candidate to Phase 3
Additional data from Apnimed’s Phase 2 MARIPOSA study later this year will inform the final design of the planned Phase 3 studies.
Read MoreAdditional data from Apnimed’s Phase 2 MARIPOSA study later this year will inform the final design of the planned Phase 3 studies.
Read MoreThe Safe Sleep for Babies Act of 2021 will add inclined sleepers for infants and crib bumpers to the list of banned hazardous products.
Read MoreDental sleep startup SleepArchitects, Newport Beach, Calif, was picked as one of the five participating startups out of 100+ applicants.
Read MoreParenting journalist Lisa L. Lewis has written a guide for parents that synthesizes the research on teen sleep and provides practical info.
Read MoreExpansion of dronabinol’s use into OSA and other therapeutic indications will require new, improved formulations, according to RespireRx.
Read More